Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
University of California, San Francisco · UCSF Helen Diller Family Comprehensive Cancer Center · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
577
total citations
- FWCI
- 43.28
- Percentile
- 100%
- References
- 39
Citations per year
Authors
29- CMCollin M. BlakelyCorresponding
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- TBThomas B.K. Watkins
The Francis Crick Institute, Cancer Research UK, CRUK Lung Cancer Centre of Excellence, University College London
- WWWei Wu
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- BGBeatrice Gini
University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center
- JJJacob J. Chabon
Stanford University
Topics & keywords
Topics
Keywords
- Biology
- Lung cancer
- Cancer research
- Mutant
- Epidermal growth factor receptor
- EGFR inhibitors
- Targeted therapy
- Cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.